Sotalol, a beta blocker and a class III antiarrhythmic agent, is the most effective antiarrhythmic agent in ARVD . Other antiarrhythmic agents used include amiodarone and conventional beta blockers ( i . e . : metoprolol ).
32.
Sotalol, a beta blocker and a class III antiarrhythmic agent, is the most effective antiarrhythmic agent in ARVD . Other antiarrhythmic agents used include amiodarone and conventional beta blockers ( i . e . : metoprolol ).
33.
Hattori Y, Inomata N, Aisaka K, Ishihara T . Electrophysiological actions of N-( 2, 6-dimethylphenyl )-8-pyrrolizidine-acetamide hydrochloride hemihydrate ( SUN 1165 ), a new antiarrhythmic agent.
34.
"' Antiarrhythmic agents "'are a group of pharmaceuticals that are used to suppress abnormal rhythms of the heart ( cardiac arrhythmias ), such as atrial fibrillation, atrial flutter, ventricular tachycardia, and ventricular fibrillation.
35.
A recent study has suggested the use of certain antiarrhythmic agents, particularly quinidine, may be of benefit in individuals with short QT syndrome due to their effects on prolonging the action potential and by their action on the I K channels.
36.
9 . Hattori Y, Hidaka T, Aisaka K, Satoh F, and Ishihara T . Effect of SUN 1165, a new potent antiarrhythmic agent, on the kinetics of rate-dependent block of Na channels and ventricular conduction of extrasystoles.
37.
Hidaka T, Hamasaki S, Aisaka K, Ishihara T, Morita M, Toyama J, and Yamada K . N-( 2, 6-dimethylphenyl )-8-pyrrolizidineacetamide hydrochloride hemihydrate ( SUN 1165 ), a new antiarrhythmic agent : effects on cardiac conduction.
38.
Antiarrhythmic agents that exhibit reverse use-dependence are more efficacious at preventing a tachyarrhythmia than converting someone into normal sinus rhythm . " Because of the reverse use-dependence of class III agents, at low heart rates class III antiarrhythmic agents may paradoxically be more arrhythmogenic ."
39.
Antiarrhythmic agents that exhibit reverse use-dependence are more efficacious at preventing a tachyarrhythmia than converting someone into normal sinus rhythm . " Because of the reverse use-dependence of class III agents, at low heart rates class III antiarrhythmic agents may paradoxically be more arrhythmogenic ."
40.
However, the options for antiarrhythmic agents are limited because certain agents can be proarrhythmic in the setting of myocardial dysfunction in TIC . Therefore, RF catheter ablation is often a safe and effective choice for treatment VT and PVCs causing TIC . In cases where other treatment strategies fail, AV node ablation with permanent pacemaker implantation can also be used to treat the tachyarrhythmia.
